We are live on ! Find out more
AHCO icon

AdaptHealth

22 hedge funds and large institutions have $110M invested in AdaptHealth in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 1

69% more funds holding

Funds holding: 1322 (+9)

49% more capital invested

Capital invested by funds: $73.5M → $110M (+$36M)

11.87% more ownership

Funds ownership: 24.41%36.28% (+12%)

Holders
22
Holders Change
+9
Holders Change %
+69.23%
% of All Funds
0.5%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
7
Reduced
1
Closed
Calls
$370K
Puts
Net Calls
+$370K
Net Calls Change
-$2.04M

AHCO Hedge Fund Activity: Q3 2018 in Review

22 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q3 2018, worth a combined $110M — up 49% from $73.5M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AHCO positions and 0 closed out — a net gain of 9 holders — while 7 added to existing stakes and 1 trimmed.

The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $19.4M. The largest seller was AQR Arbitrage, cutting an estimated $10.7M.

  • 22 institutional investors held AdaptHealth (AHCO) as of Q3 2018, up from 13 in Q2 2018.
  • Funds reported $110M of AdaptHealth stock for Q3 2018, up 49% quarter-over-quarter.
  • 9 funds opened new AdaptHealth positions in Q3 2018 and 0 closed out, a net change of +9 holders.
  • The largest AdaptHealth buyer in Q3 2018 was Highbridge Capital Management, an estimated $19.4M added.
  • The largest AdaptHealth seller in Q3 2018 was AQR Arbitrage, an estimated $10.7M sold.

Based on aggregated 13F filings for Q3 2018.